Patents Assigned to ACTIMED THERAPEUTICS LTD
  • S-enantiomerically enriched compositions of beta blockers for treating muscle weakness
    Patent number: 11382876
    Abstract: The use of S-enantiomerically enriched compositions of beta blockers for treating muscle weakness. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: July 12, 2022
    Assignee: Actimed Therapeutics LTD
    Inventors: Stefan Anker, Andrew J. S. Coats
  • S-enantiomerically enriched compositions of beta blockers for treating muscle weakness
    Patent number: 11096908
    Abstract: The use of S-enantiomerically enriched compositions of beta blockers for treating muscle weakness. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: August 24, 2021
    Assignee: Actimed Therapeutics LTD
    Inventors: Stefan Anker, Andrew J. S. Coats
  • S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
    Patent number: 10449166
    Abstract: The present invention relates to S-enantiomerically enriched compositions of beta blockers and uses thereof, including uses of the beta blocker compositions for treating amyotrophic lateral sclerosis. The beta blocker compositions can also be used for preventing loss of lean mass, preventing body weight loss in subjects, improving quality of life in subjects, and prolonging survival in amyotrophic lateral sclerosis patients. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: October 22, 2019
    Assignee: ACTIMED THERAPEUTICS LTD
    Inventors: Andrew J. S. Coats, Stefan Anker, Jochen Springer